Intellia Therapeutics CRISPR Breakthrough: Pivotal Success

Intellia Therapeutics Achieves Landmark Success in In Vivo CRISPR Gene Editing Trial for Hereditary Angioedema In a move that could redefine the future of genomic medicine, Intellia Therapeutics has announced that its groundbreaking in vivo CRISPR gene editing therapy has successfully met its primary endpoint in a pivotal Phase 3 clinical trial. The trial focused … Read more

FDA Drops Suicide Warnings From Weight Loss Drugs

Nearly 40% of U.S. adults are now considered obese, a figure that continues to climb despite decades of public health campaigns. But the narrative is shifting. The recent decision by the FDA to request the removal of suicide warnings associated with GLP-1 receptor agonists – drugs like Wegovy and Ozempic – isn’t simply a retraction … Read more